IPO Central

Clean Science IPO description – Clean Science and Technology is among the few companies globally focused entirely on developing newer technologies using in-house catalytic processes, enabling it to emerge as the largest manufacturer of certain specialty chemicals in terms of manufacturing capacities. The company manufactures functionally critical specialty chemicals such as Performance Chemicals (i.e. MEHQ, BHA and AP), Pharmaceutical Intermediates (i.e. Guaiacol and DCC), and FMCG Chemicals (i.e. 4-MAP and Anisole).

As of 31 December 2020, it was the largest manufacturer globally of MEHQ, BHA, Anisole and 4-MAP, in terms of manufacturing capacities. Most of its production processes are either zero liquid discharge or release only water as discharge. In FY2020 and in the nine months ended 31 December 2020, exports represented 68.8% and 65.4% of its total revenue from operations, respectively.

Its products are used as key starting level materials, as inhibitors, or as additives, for products sold in regulated markets. Its major customers include Bayer AG, SRF Limited, Gennex Laboratories Limited, Nutriad International NV and Vinati Organics Limited.

Promoters of Clean Science and Technology – Ashok Ramnarayan Boob, Krishnakumar Ramnarayan Boob, Siddhartha Ashok Sikchi and Parth Ashok Maheshwari